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Abstract
Background: New opportunities to record, collate, and analyze routine patient data have prompted optimism
about the potential of learning health systems. However, real-life examples of such systems remain rare and few
have been exposed to study. We aimed to examine the views of design stakeholders on designing and
implementing a US-based registry-enabled care and learning system for cystic fibrosis (RCLS-CF).
Methods: We conducted a two-phase qualitative study with stakeholders involved in designing, implementing, and
using the RCLS-CF. First, we conducted semi-structured interviews with 19 program personnels involved in design
and delivery of the program. We then undertook 11 follow-up interviews. Analysis of interviews was based on the
constant comparative method, supported by NVivo software.
Results: The organizing principle for the RCLS-CF was a shift to more partnership-based relationships between
patients and clinicians, founded in values of co-production, and facilitated by technology-enabled data sharing.
Participants proposed that, for the system to be successful, the data it collects must be both clinically useful and
meaningful to patients and clinicians. They suggested that the prerequisites included a technological infrastructure
capable of supporting data entry and joint decision-making in an accessible way, and a set of social conditions,
including willingness from patients and clinicians alike to work together in new ways that build on the expertise of
both parties. Follow-up interviews highlighted some of the obstacles, including technical challenges and practical
constraints on refiguring relationships between clinicians and patients.
Conclusions: The values and vision underlying the RCLS-CF were shared and clearly and consistently articulated by
design stakeholders. The challenges to realization were often not at the level of principle, but were both practical
and social in character. Lessons from this study may be useful to other systems looking to harness the power of
“big data” registries, including patient-reported data, for care, research, and quality improvement.
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Background
Supporting patients with chronic conditions in ways that
fully respect their needs, values, capabilities, and prior-
ities remains a challenge for health systems [1, 2]. At the
same time, there is a growing requirement for better
data to support improvement in care quality and to fa-
cilitate research that is relevant to the needs and prior-
ities of patients and clinicians [3]. One promising
approach to addressing these imperatives lies in the con-
cept, originally proposed by the Institute of Medicine, of
the learning health system [4, 5]. Leveraging the capabil-
ities of electronic health records and other digital re-
sources, learning health systems seek to support
collaborative healthcare choices of patients and clini-
cians, generate new knowledge as an “ongoing, natural
by-product of the care experience” [6], and facilitate im-
provements in quality, safety, and value [7].
Though articulated in various forms, the underlying
concept is straightforward: harness the power of
data and analytics to learn from every patient, and
feed the knowledge of “what works best” back to cli-
nicians, public health professionals, patients, and
other stakeholders to create cycles of continuous
improvement [8].
Despite enthusiasm for the principles of a learning
health system, few real-life examples exist [9, 10] such
that “a learning health system remains an aspiration ra-
ther than an achievement” [3]. The risk is that, unless
early models are studied [11], learning health systems
may not mature to the point where their ambitions can
be delivered. In this article, we report a study of the
views of design stakeholders of a program known as “En-
abling Uptake of a Registry-Supported Care and
Learning System in the US” (RCLS) for people with cys-
tic fibrosis (CF). Funded by the Robert Wood Johnson
Foundation and the Cystic Fibrosis Foundation, the
RCLS-CF was led by a team from The Dartmouth Insti-
tute for Health Policy & Clinical Practice (TDI) in New
Hampshire, USA, with support from the US Cystic Fi-
brosis Foundation, and advice from Cincinnati Chil-
dren’s Hospital Medical Center, Cincinnati, OH, USA,
and the Karolinska Institutet in Stockholm, Sweden.
The RCLS-CF is an important example for several rea-
sons. First, it is based on a defined patient population ra-
ther than a single organization. Second, it combines data
from a patient registry of clinical measures with newly
recorded patient-reported data to feed a distinctive elec-
tronic dashboard that can be viewed jointly by patients
and clinicians and used as a basis for collaborative
shared review, planning, and decision-making [12].
Third, the data can be repurposed for research and ser-
vice improvement. Fourth, the RCLS-CF explicitly seeks
to learn from the achievements and experiences of other
programs that share some of the characteristics of the
learning system approach. In particular, it builds on the
work of Swedish and American programs that seek to fa-
cilitate real-time input of data by patients [13] [14, 15],
joint review of data by clinicians and patients during
clinic appointments [16], and co-design of systems by
patients, families, clinicians, and researchers [17–19].
We conducted a qualitative study of the RCLS-CF
learning system to examine perspectives of the health
professional design stakeholders, seeking in particular to
articulate their major assumptions about the essential
features of the program and what would be required to
make it work [20–24].
Methods
We conducted the study in two phases. In early 2016,
the first phase of the study involved semi-structured in-
terviews with health professional stakeholders involved
in designing, advising, implementing, and evaluating the
RCLS-CF. The program director invited 20 health pro-
fessionals (i.e., front line interdisciplinary team members
and other professionals closely engaged in the design of
the project) to take part in a confidential interview.
These personnel included program designers [5], pro-
gram advisors [7], pilot site leaders [5], and program
sponsors/funders [3]. Purposive sampling was used to
ensure a balance of individuals such as site leaders to
avoid over sampling, but otherwise, all the major profes-
sional stakeholders were invited to take part. Interviews
were conducted by telephone or Skype with 19 partici-
pants shortly after the program began. One individual (a
program advisor) was not interviewed owing to schedul-
ing difficulties.
Contributions to the literature
 The concept of a learning system has been enthusiastically
embraced in healthcare, but relatively few real-life examples
exist and even fewer have been evaluated.
 It is important to articulate the assumptions and values that
underlie learning systems and to characterize the challenges
they may face.
 Interviews with design stakeholders involved in developing
and implementing a US learning system showed that they
were commited to realizing authentic partnerships between
patients and clinicians, facilitated by a shared clinical
dashboard fed with data by both parties.
 They also identified technical and social challenges to
achieving this ideal, offering practical learning for others
seeking to implement learning systems.
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The second phase of the study sought to deepen under-
standing of the findings generated in the first phase and to
identify any changes that might have occurred over time in
light of experience. In spring 2018, the project director in-
vited 17 of the original interviewees to participate in a fur-
ther interview (excluding only three who were no longer
involved in the program). Three declined to be interviewed
due to lack of engagement in the program since its incep-
tion; three did not respond to the interview request. In
total, 11 stakeholders were re-interviewed by phone; they
included a program designer [1], program advisors [4], pilot
site leaders [4], and program sponsors/funders [2].
The interview guides in both phases were informed by
the TiDIER [25] framework for describing interventions.
They included questions about what participants per-
ceived to be the essential components of the program,
how they were expected to work, and the contextual fac-
tors perceived to have impact on the successful replica-
tion of the program. The first round of as interviews was
carried out by AC; the follow-up interviews were carried
out by TC. AC is a doctorally trained health service re-
searcher; TC is prepared in public health, who con-
ducted the study in partial fulfillment of the
requirements of a master’s dissertation. Neither had any
relationship with the program team. All interviews were
digitally recorded. Interview recordings were transcribed
verbatim. Transcripts were anonymized to remove any
identifying details. Full transcripts were not shared with
the RCLS-CF team.
Analysis of interviews was based on the constant com-
parative method [26], using initial sensitizing constructs
from the TIDieR framework to examine the transcripts.
New codes were iteratively developed as analysis contin-
ued, and higher order thematic categories were devel-
oped. Trustworthiness was enhanced by the involvement
of different team members in analysis and refinement of
the themes, and through the use of NVivo 11 software
to manage the coding and analysis process and facilitate
a systematic and transparent approach to coding. Cred-
ibility was enriched by checks to ensure that the themes
were adequately comprehensive, with no relevant data
excluded or irrelevant data included [27]. Credibility was
also secured through sharing of the themes with mem-
bers of the authorship team who were also directly in-
volved with the RCLS-CF (AVC, KAS, ECN), who
provided further insights derived from their own experi-
ence of the program.
Both phases of the study were approved by the Dart-
mouth College Committee for the Protection of Human
Subjects (Study: 00028656, approved 23 September
2015). All participants gave written informed consent.
Results
Interviews with participants allowed characterization of
the key elements of the RCLS-CF learning system (Table
1) as understood by the health professional design stake-
holders. In the account that follows, we examine, first,
the vision and foundational concepts of the learning sys-
tem that were identified by participants; second, partici-
pants’ views of the technical prerequisites; third, their
views of the social conditions necessary for program im-
plementation; and finally, challenges in implementation.
Except where relevant, we do not draw contrasts be-
tween the first part of data collection and the second, in-
stead presenting findings that endured between the two
phases. We identify interviews as arising from the first
phase of data collection as 1-, and from the second
phase as 2-, in the tags that follow data excerpts.
Design stakeholders’ views of tthe foundations of RCLS-
CF: co-production and its transformational potential
The program team developed a high-level conceptual
model that sought to link people, information, and
knowledge generation to achieve better health (Fig. 1),
Table 1 Summary of key components of the registry-enabled learning system (RCLS-CF)
Topic Core idea
Program origins • The program is informed by and to some extent modeled on existing initiatives
• The program is informed by two important ideas: the learning health system and co-production
Design principles • A shift to more partnership-based relationships between patients and clinicians can be facilitated by new forms of technology-
enabled data-sharing
• Data generated by patients and clinicians can be repurposed for other uses, including research and service improvement
• The key stakeholders must be involved in co-design of RCLS-CF
• The data collected must be meaningful to patients and clinicians and reflect their priorities
Design constraints • The technology will need to be smooth, effective, and time-efficient to use
• Ensuring security and privacy of data will be essential
Implementation
tactics
• Program Scope: The RCLS-CF program will focus primarily on developing the dashboard that reflects patient’s goals, treatments,
and outcomes
• Securing universal support from clinicians and patients may be challenging
• The project is complex and may generate some frictions
Risk mitigation • The program may create additional burdens and risks for patients
• The program may create or be influenced by forms of inequity
The information in this table is based on stakeholder interviews with RCLS-CF program designers, advisors, leaders from pilot sites, and program sponsors/funders
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and this remained intact over time. In both parts of the
study, participants expressed strong consensus on the
goals of the program: to use new, digitally enabled forms
of sharing data (both patient-generated and clinical) to
change the dynamics of healthcare, with the ultimate aim
of facilitating better partnerships between patients, fam-
ilies, clinicians, researchers, and healthcare improvers.
At the center of this technical infrastructure was a
dashboard intended to put patient-reported and clinical
data on an even keel, allowing patient and clinician to
attend to both, to understand their interactions, and to
adjust therapeutic regimes to optimize management of
the condition in light of both patient and clinician prior-
ities. In practical terms, the program viewed every clin-
ical interaction and every patient input to the system as
an opportunity to generate meaningful and usable
knowledge that could improve individuals’ health out-
comes and support decision-making, and could also po-
tentially contribute to a knowledge base that could be
used for scientific discovery and service improvement.
An especially prominent feature of participants’ ac-
counts of the program in both phases was an emphasis
on ideas of co-production [28]. As they saw it, co-
production provided a value-based framework through
which it would be possible to redefine the nature of care
delivery and the relationship between patients and clini-
cians, enabling it to be more dialogical, more equitable,
and more facilitative of shared decision-making.
Well the heart of it is the partnership for co-
production. That’s kind of where the magic hap-
pens. (1-06 Sponsor/funder)
Fig. 1 Conceptual model of the RCLS-CF program: linking people, information, and knowledge generation for better health
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Participants described a vision where better conversa-
tions, grounded in patients’ priorities, would allow better
care to be co-created. Achieving this would mean pro-
viding patients with the means to identify the metrics
most important to them, to report on what was happen-
ing between clinic visits, to shape the agenda of visits,
and to work with clinicians as equal partners.
The way that I see the basics of this, is that you
know we are putting patient-reported data, […] and
some of the clinically collected data, on the same
playing field. (1-16 Advisor)
In the follow-up (phase 2) interviews, participants sug-
gested thinking of the clinical encounter as involving
two experts: the clinician, an expert in biomedical know-
ledge, and the patient, an expert in their own experience
of living with a life-limiting illness. It was proposed that
this reconfigured relationship would result in new forms
of partnership.
The social relationship starts to often change when
successful, that by creating this new information en-
vironment the ability to have a more equal relation-
ship, where we have... discovered this phrase, two
experts in the room, the patient is an expert on
their own results and what seems to be working for
them and how this...the disease and its treatment
can fit into their life. The physician, clinician is the
expert in what biomedical science might have to say
about treating the diseases or disease or the condi-
tions that the person has. So now we have two ex-
perts in the room, that’s new. (2-05 Designer)
Looking at the data together during clinic visits, and
organizing discussions around it, was specifically
intended to provide the basis for better conversations,
shared decision-making, and, ultimately, better health
outcomes for the individual patient.
I would say the aim is to really change the model of
care to […] a model that was previously more trad-
itional […] top-down, where the provider was more
the decision maker, and […] the patient was more
passive to a model that is more of a partnership be-
tween the patient and the, the patient, family, and
the team. (1-12 Pilot Site Leader)
I think we’ll get much better outcomes if we engage
patients in their own care. And part of that is elicit-
ing what are the goals of care for the patient and
then constructing a, sort of, shared decision making,
you know, a goal informed by shared decision mak-
ing. (2-03 Advisor)
The underlying assumption was that the registry-
enabled approach would promote shared understanding
of the data and therefore joint decision-making. The in-
formation generated by patients and clinicians could also
be used for wider purposes in keeping with the ethos of
the learning health system: the growing trove of data in
the registry could also be used for research and for ser-
vice improvement.
The learning health system is a wonderful idea, it is
a really cool thing where you know every time
people meet, any data that is gathered is then sort
of hoovered up and turned into knowledge that is
then applied to the point of care so that people can
make better decisions. So you know the connection
between the two is you know if you have these
highly productive, co-produced clinical interactions,
then the knowledge, the data that starts generating
as a result of those interactions is somehow contrib-
uted to the greater pool of knowledge. (1-10
Advisor)
Consistent with these principles, a process of “co-de-
sign,” in which representatives of key groups had been
involved in formulating and planning the program from
an early stage, was seen as important to ensuring that
the program was grounded in co-production and could
address both technical and social challenges. Participants
emphasized that co-design of the dashboard was both an
ethical imperative and necessary to ensuring that the
system would secure engagement.
We have a very active co-design process, we have
representatives. I think of it as the lead team […] we
have involved interdisciplinary clinical teams, in-
cluding patients and family members in each of
those five settings, they are the lead teams that are
looking at this model that we are looking at, and
coming to understand it, and helping to decide what
those dashboards look like, what the information
technology solution approach will be and the CF
Foundation is at the table as well. (1-15 Advisor)
Participants consistently identified the key stakeholders
in the project as the patients and their families, the care
team, and the Cystic Fibrosis Foundation, as well as senior
executives in individual organizations. Others included
electronic health record vendors, specialist pharmacies, re-
searchers, and regulators and payers.
So we have a coalition of patients, providers, re-
searchers and industry participation. And that coali-
tion of stakeholders makes it possible for all
participating organizations to negotiate the values of
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the different stakeholders in participation. And it
also makes it possible for the stakeholders to negoti-
ate core data sets that have big importance for all
stakeholders. So that organizational dimension is
very important. (2-06 Advisor)
Design stakeholders’ views of the technical prerequisites
for the learning system
Participants emphasized that facilitating more co-produced
care plans, informed by both clinical and patient-reported
data, would need to be supported by a point-of-care dash-
board that could be viewed in clinical consultations by pa-
tient and clinician together. By collecting and storing patient
and clinical data from the CF Foundation Patient Registry to-
gether in the dashboard, the assumption was that patients
would be able to reflect on the course of their disease, symp-
toms, and medical interventions and develop their own goals
and share them with clinicians. This would require a means
for patients to select measures that were important to them
and to capture their own data on events (e.g., ability to par-
ticipate in daily activities or exercise), symptoms occurring
between clinic visits, and variations in their clinical status
(e.g., weight, lung function) over time. Participants described
how patient-reported and clinical data would feed the elec-
tronic dashboard and simultaneously supply the CF Founda-
tion Patient Registry with patient-reported outcomes.
The three-year goal is much more specific and that
is to take components of this larger model, and to
make it possible to have a dashboard at the center
of the model, that can be used at the point-of-care,
when patients and clinicians get together, to help
see how the person is doing. To help make deci-
sions about how well the treatment plans are work-
ing, to help inform the conversation about the best
next steps in the treatment plan, based on patient
preference and evidence base. (1-15 Designer)
Participants identified that for these goals to be achieved,
the technical infrastructure would need to meet several key
requirements. In particular, it would need to be technically
capable of supporting clinical care, research, and improve-
ment; create an easy, non-frustrating way for patients to
record data and make direct inputs to their own health re-
cords; help clinicians to record and view key clinical mea-
sures without irritating them or slowing them down; and
enable both sets of data (patient-generated and clinician-
generated) to be displayed visually for easy use by patients,
families, and clinicians as part of routine visits.
The technology is the first part. Like you have to
have solid technology that is really easy to use and
you know, not buggy, and fast, and all those import-
ant things. (1-16 Advisor)
Probably the critical components [are] ... aggregat-
ing the medical data in a way that is easily digest-
ible, and the patient-reported outcome measures,
getting them, getting them in real time, organized in
a way that’s easily digestible and available to all par-
ties. (1-06 Sponsor/funder)
Participants described the need for an interface that
was smooth and fast, where end-users could enter data
in real time via multiple channels and enjoy flexibility in
the types of data that could be entered. It also needed to
avoid any double entry: participants emphasized the
principle of “data in once.”
It needs to be today’s data is actually entered in the
dashboard. So we can say how are you doing today
and what are the things contributing and, you know,
do we need to make changes. (1-19 Pilot Site
Leader)
What I worry about is, it may create the need to do
more data entry that is manual between all of these
systems to get what we really want up and going.
[…] I think there are huge burdens between our
current clinic [electronic medical record] system,
our hospital system none of these are at the mo-
ment interoperable and that, I worry about where
the burden of getting that data is going to fall if it
doesn’t seamlessly flow with this project. (1-12 Pilot
Site Leader)
In practice, multiple technical problems emerged in
achieving the seamless, on-demand flow of data that the
designers sought. By the phase 2 interviews, participants
were stressing many of the challenges:
The platform we were using wasn’t real time, so you
didn’t have today’s data there and you only had up
till the previous visit’s data, and any discussion
really centers around how are things going at to-
day’s appointment, and where is your lung function
today? So you absolutely have to have real time data
and that’s crucial." (2-04 Site lead)
Although it’s workable in theory we didn't succeed
in our four pilot sites in getting single sign- on and
we did not succeed in getting two-way exchange of
real time data. We could get...for example we
couldn’t get real- time clinical results that are fun-
damental, FEV1 and body mass index, that was al-
ways lagged. So today’s values for body mass index
and today’s value for lung function, FEV1, weren’t
there. The historical dates were, data points were
but not today’s," (2-02 Program designer)
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During the initial interviews, participants reported that
the program would need to work within, or alongside,
current electronic healthcare record systems and have
appropriate security protections and permissions for ac-
cess. Participants consistently identified the complexity
of the healthcare system in the USA as a challenge to
the technical feasibility of the program, with interoper-
ability a particular threat that was especially prominent
in the second phase of interviews.
And the interoperability of data, from, if we want to
produce a single dashboard for example, if we de-
cide to do that then we’ll have to deal with inter-
operability challenges […] data in one system is not
always defined the same as it is in another system
[…] so we have to make sure there’s clear mapping
between, or from different systems on to the dash-
board. (1-08 Designer)
And then the other part of the programme was to
try and implement this through an electronic fea-
ture or system. But [pause] the system, electronic
system, didn't work because we lacked the infra-
structure ability to make it inter-operable with the
charts" (2 – 03 Site Lead)
Design stakeholders’ views of the social conditions
necessary for program implementation
Though optimizing and resolving technical issues were
seen as important to ensuring that the program could
work, participants were also cognizant of wider contexts.
They recognized that the program might not gain uni-
versal support and identified many social, cultural, and
practical barriers that might prevent clinicians and pa-
tients from engaging with the program. Participants
noted that not all people with CF would find the dash-
boards appealing or easy to use. Some patients might re-
vert to passivity, preferring to simply listen and follow
advice from clinicians rather than engaging as partners.
I think for some patients it will also be difficult in
that patients like to view their doctor as knowing
everything and the idea that doctors need to share
for patients beyond the just regular questions that
are asked may be difficult for some patients to come
to terms with […] a patient may never expect a doc-
tor to know like what is going on in the home. (1-
09 Pilot Site Leader)
Feeding forward patient-reported information would, it
was acknowledged, add to the burden of data collection for
patients who already spent much time on self-care. Engage-
ment might further be influenced by factors such as liter-
acy, education, self-efficacy, and access to the relevant
technology. It was suggested that the majority of patients,
regardless of socio-economic background, might require
some sort of education on data collection and interpret-
ation and which data would be termed “meaningful”:
It could be with, you know, with some training,
maybe somebody on the care team sort of goes
through the form back and forth with them a time
or two, and make sure they understand the ques-
tions and the rating scale, just so that they have a
proper level with it. And there may be some where
they just not interested or the challenge of trying to
complete that form is just beyond their capabilities.
(1-06 Sponsor/funder)
Different patients are more or less ready for co-
production. So we have to sort of meet patients
where they are, so it has to sort of cross the
spectrum of patients’ readiness for being involved in
their care and…what their values are and what their
views are in terms of co-producing as opposed to,
you know, being more explicitly guided. (2-04 Site
lead)
While it was identified that some clinicians might not
see the value in using patient-generated data and might
be reluctant to try out new ways of partnering with pa-
tients, a more practical barrier was the pressurized con-
text of clinic visits and the risk of data overload.
I think the medical system right now is very rushed,
and while this may add efficiencies to those conver-
sations, I’m hoping that it doesn’t to a point where
time isn’t allocated, enough time isn’t allocated to
have the right conversations at the right time. (1-07
Designer)
Understanding how the program affected clinicians’
workflow was particularly important for its success. Clini-
cians often had busy schedules and very limited time to see
patients. If the program and its associated activities occu-
pied much of their time without demonstrating substantial
benefits to both the patient and the clinician, then partici-
pants predicted that it was destined to sub-optimal use.
So, there are two aspects to this and I’m going to
call them humanware and software. Humanware is
just how we organize ourselves and our clinic. Do
we create this space to capture the patient’s goals,
to address the patient’s goals? Do we have time to
discuss them and actually follow through on them?
So, that’s one aspect, right? And that doesn’t need
technology. It needs, just, you know, workflow
reorganization. (2-03 Advisor)
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Participants proposed that both patients and clinicians
would have to be open to changing their expectations and
ways of thinking (and working) about how healthcare is de-
livered in a clinical environment informed by the values of
co-production. Patients would have to learn how to use the
application, how to reflect on their experiences, and how to
set up and articulate their goals for their care and treatment
clearly. From the other side, the clinicians would have to
learn how to allow patients to lead the clinical consultation,
how to actively help them to formulate the clinical encounter
around their goals, and how to best manage any negative
emotions that patients might experience, for example, by
realising through their data that their health is deteriorating.
So patients need to understand how they can con-
tribute to this co-production of service. And profes-
sionals need to understand how they can contribute
to this co-production of services, and the relation-
ship of patient and professional itself has to develop
a capability for this co-productive work, this inter-
dependent work if in fact we will be successful go-
ing forward. (2-02 Advisor)
The assumption was that specifically asking patients
about their key concerns and goals would lead to better
identification of patients’ needs, which in turn would
support a clinical interaction explicitly centered around
what the patient sees as important for their care and
health.
So I think that the most important feature is actu-
ally explicitly asking patients what their question-
s...you know, their main concern, their main
question of priority for the visit, actually being...
You know, being explicit in asking the key question.
So, you know, what is your main concern and what
do you want to get out of this? Because I think that
I assumed I knew that, but I never asked it expli-
citly. (2-11 Pilot Site Leader)
Design stakeholders’ views of tensions and challenges in
implementing the learning system
Participants discussed the possibility of various tensions
in implementing the learning system that might arise be-
tween the multiple stakeholders, largely seeing them as
inevitable but manageable.
I think we all come in with a pretty common pur-
pose of, you know, wanting to improve the quality
of life and length of life for people with CF, I think
we’re all committed to that. So yeah, I think there
are struggles with moments of tension, but ultim-
ately we push through them, because I think we all
come in with the same objective. (1-07 Designer)
During the follow-up interviews, the commitment to
common purpose and shared vision did not waver, but
what was required to deliver it was the focus of some
disagreement between stakeholders. Some, for instance,
felt that the scope of the project had been too ambitious
at the start and accordingly was vulnerable at both a
technical and social level.
I think what’s the minimum...what’s the stimulus to
really get the two parties to engage in a meaningful
interaction and what do the healthcare professionals
need, what the patients and families need to feel like
they’ve got a stake in the outcome of that inter-
action? And that could be just simply that they’re
able to right at the beginning state what happe-
ned...what their agenda items are, clarify the agenda
at the beginning of the encounter. I think this first
iteration, this first dashboard could probably...some-
thing less ambitious could have helped the two par-
ties set the right agenda for the meeting and result
in a more productive interaction. (2-01 Program
sponsor )
One view was that the realization of the dashboard
concept in practice had deviated from the initial design
requirements, particularly around usability and relevance
for both patients and clinicians. They suggested a form
of “scope creep” had shifted the focus of the dashboard.
I think the scope and the aim of the project has sig-
nificantly broadened to the point where, initially I
think we were focused on creating like one page or
one screen or one just all-encompassing dashboard
of an electronic platform to generate this discussion,
and instead it kind of turned into a: how do we get
every patient, every parent access to all of the data
ever collected on their child or themselves that ex-
ists within the national registry. (2-08 Pilot Site
Leader)
The breadth of information meant that some stake-
holders felt that the dashboard risked obstructing rather
than supporting the clinical consultation. Though some
information might be important to patients’ day-to-day
monitoring, much information not immediately relevant
to that day’s appointment might mean that for clinicians
at least, the system could lose its appeal and deter them
from engaging with the dashboard.
I think that it became too much, so trying to sort of
graph every patient symptom, every patient-
reported detail, it was too much and it became... It
was so big and so much that it became unusable.
The platform we were using wasn’t real time, so you
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didn’t have today’s data there and you only had up
till the previous visit’s data, and any discussion
really centers around how are things going at to-
day’s appointment, and where is your lung function
today? So you absolutely have to have real-time data
and that’s crucial. (2-11 Pilot Site Leader)
Lack of inter-operability between the dashboard and
patients’ electronic medical records remained another
important limitation. In the follow-up interviews, some
reported that it took valuable time navigating between
registries and databases where patient-reported data
were held, posing a practical frustration to the
realization of the vision of co-production.
So, it seemed like we went from a very contained and
we just create a way to generate discussion and
problem-solving as a team in clinic to now how do we
give families access to all of this data, and started to gen-
erate a website or an application that was incredibly big
and cumbersome and very difficult to unify as a clinical
tool within the outpatient clinic study." (2-01 Site lead )
It was apparent for many that the wider technological
infrastructure that could support the delivery of such a
program to its full potential was still missing. Other con-
cerns related to the potential for the system to operate
forms of “surveillance” of both clinician and patient “per-
formance.” Participants were concerned, for example,
about the extent to which candid conversations could take
place if patients were afraid of being judged based on self-
care data. Some suggested that patients and clinicians
might be tempted to “game” data, to avoid judgement
from paternalistic clinicians or managerial systems.
And, when of course when you know people are col-
lecting data for what they perceive as judgement there
are all kinds of things that will happen, you know se-
lective reporting, you know people start to do things
that, to change the numbers. (1-10 Advisor)
Participants hoped that encouraging openness, refrain-
ing from judgment, and using co-production to establish
what treatment regimen would be feasible for a particu-
lar patient might reduce discomfort with data reporting
and diminish incentives to enter inaccurate data. Such
issues did not weigh as heavily in the second set of inter-
views, suggesting perhaps that in practice, the potential
benefits of the system outweighed any lingering con-
cerns about surveillance.
Discussion
Much has been written about the potential of the learn-
ing health system concept [29]. Yet, few real-life systems
have been described in detail or evaluated. Without
evaluative insights into early iterations of such systems,
their rich potential might be squandered [11]. This study
presents the views of design stakeholders of one promis-
ing learning health system and identifies from early ex-
periences where the challenges might lie in moving from
design principles to intended outcomes.
The vision and values informing the RCLS-CF—a
registry-based learning system for cystic fibrosis—
enjoyed a high degree of consensus among the health
professional design stakeholders we interviewed, and
remained stable between the two phases of interviews
(reflected, for example, in an unchanged high-level
model—Fig. 1). The founding principle was that, by real-
izing the principles of co-production [28], a learning sys-
tem could support patients and clinicians to become
confident, competent, and equal partners who can share
decisions [30], thus countering the traditional tendency
for medical consultations to neglect patients’ views in
favor of biomedical understandings and prioritize clinical
metrics over patients’ lived experiences [31]. Participants
proposed that this kind of learning system would not
only generate benefits for patients, but also for research
and service improvement.
In practice, the challenges to realizing this vision did
not arise from any fundamental disagreement about the
underlying objectives or values. Instead, one set of obsta-
cles was, in many ways, quite mundane in character [32]:
It involved the technical problems of trying to align sys-
tems and data in ways that would be consistent with the
strategic vision. Participants pointed, for example, to the
need for a parsimonious dataset, not least to avoid
drowning in the the ocean of potential insights offered
by “big data.” A second set of challenges arose because
of difficulties in seeking to refigure traditional forms of
clinician-patient relationship. Some of these were seen
to be social in character, for example, linked to the dis-
comforts of relinquishing long-established and trad-
itional patient-professional relationships. However, many
other problems were seen to arise in seeking to imple-
ment changes when time and resource constraints re-
main real deterrents to shared decision-making [33].
These findings add to the growing body of evidence that
highlights highly mundane, practical challenges as a
source of trouble in implementing grand visions [32].
A strength of this study was its longitudinal component,
gaining insights from stakeholders both before and after
implementation of the system. However, a notable weak-
ness was that it did not include patients or patient repre-
sentatives. Patients’ perspectives on the dashboard might
have differed quite substantially from those of clinicians,
sponsors, advisors, and designers, and we note in particu-
lar that they may have had very different views about the
appropriateness of the volume of data included in the
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dashboard, given the potential usefulness of these data in
managing their condition on a day-to-day basis. A further
limitation of our study was some attrition between phase
1 and phase 2 interviews. It will be important to determine
which of the principles are specific to the CF context and
to the US healthcare system and which are generalizable.
Conclusions
What is important for patients, who must live with and adjust
to a chronic condition every day, and what is important for
discussion between patients and clinicians in much more
sporadic consultations may differ [34]. Developing a learning
system that can accommodate both of these needs, as well as
serving the purposes of research and service improvement, is
not straightforward. Our study has shown that even when the
values and vision underlying a learning system are clearly and
consistently articulated by design stakeholders, implementa-
tion may be challenged by problems that are both social and
technical and that may have a strongly mundane character.
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